CN103110935B - 皮肤局部用水解胶原蛋白脂质体及其制备方法 - Google Patents
皮肤局部用水解胶原蛋白脂质体及其制备方法 Download PDFInfo
- Publication number
- CN103110935B CN103110935B CN201310030618.8A CN201310030618A CN103110935B CN 103110935 B CN103110935 B CN 103110935B CN 201310030618 A CN201310030618 A CN 201310030618A CN 103110935 B CN103110935 B CN 103110935B
- Authority
- CN
- China
- Prior art keywords
- skin
- liposome
- hydrolytic collagen
- collagen
- ceramide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 113
- 108010035532 Collagen Proteins 0.000 title claims abstract description 113
- 229920001436 collagen Polymers 0.000 title claims abstract description 95
- 239000002502 liposome Substances 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title claims description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 32
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 31
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 30
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 30
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 23
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 23
- 229940106189 ceramide Drugs 0.000 claims abstract description 23
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 23
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 23
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 17
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 16
- 230000003301 hydrolyzing effect Effects 0.000 claims description 83
- 239000000243 solution Substances 0.000 claims description 61
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 230000009514 concussion Effects 0.000 claims description 5
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000009834 vaporization Methods 0.000 claims description 3
- 230000008016 vaporization Effects 0.000 claims description 3
- 102000016202 Proteolipids Human genes 0.000 claims 1
- 108010010974 Proteolipids Proteins 0.000 claims 1
- 239000006193 liquid solution Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 55
- 238000011084 recovery Methods 0.000 abstract description 4
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 230000037380 skin damage Effects 0.000 abstract description 3
- 210000000434 stratum corneum Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 239000003814 drug Substances 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 230000008439 repair process Effects 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000028990 Skin injury Diseases 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- -1 amino, carboxyl Chemical group 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- FVXDQWZBHIXIEJ-LNDKUQBDSA-N 1,2-di-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC FVXDQWZBHIXIEJ-LNDKUQBDSA-N 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 101001105486 Homo sapiens Proteasome subunit alpha type-7 Proteins 0.000 description 2
- 102100021201 Proteasome subunit alpha type-7 Human genes 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 239000003725 proteoliposome Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 206010024604 Lipoatrophy Diseases 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000037310 combination skin Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960003724 dimyristoylphosphatidylcholine Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229940098201 hyaluronic acid 1 mg Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007514 neuronal growth Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940011964 pentobarbital sodium 30 mg Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310030618.8A CN103110935B (zh) | 2013-01-25 | 2013-01-25 | 皮肤局部用水解胶原蛋白脂质体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310030618.8A CN103110935B (zh) | 2013-01-25 | 2013-01-25 | 皮肤局部用水解胶原蛋白脂质体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103110935A CN103110935A (zh) | 2013-05-22 |
CN103110935B true CN103110935B (zh) | 2014-06-11 |
Family
ID=48409345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310030618.8A Active CN103110935B (zh) | 2013-01-25 | 2013-01-25 | 皮肤局部用水解胶原蛋白脂质体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103110935B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9248160B1 (en) * | 2015-07-28 | 2016-02-02 | Zo Skin Health, Inc. | Post-procedure skin care systems, compositions, and methods of use thereof |
CN107441046B (zh) * | 2017-08-31 | 2020-07-28 | 宁波盖济尔医疗科技有限公司 | 一种复合蛋白质脂质体纳米制剂 |
CN108785128A (zh) * | 2018-07-04 | 2018-11-13 | 肇庆市创业帮信息技术有限公司 | 一种聚丙二醇修饰的水解胶原蛋白脂质体及其制备方法 |
CN109394567A (zh) * | 2018-10-19 | 2019-03-01 | 天津工业大学 | 一种多功能透明质酸脂质体的制备方法及质检标准 |
CN109394563A (zh) * | 2018-11-06 | 2019-03-01 | 福建省海西细胞生物工程有限公司 | 一种干细胞培养基脂质体的制备方法及在护肤品中的应用 |
CN112315821B (zh) * | 2020-12-03 | 2022-09-23 | 暨南大学 | 一种水解蛋白脂质体及其制备方法与应用 |
CN113679631A (zh) * | 2021-09-28 | 2021-11-23 | 常州金远药业制造有限公司 | 一种含有透明质酸的氨甲环酸脂质体化妆品及其制备方法 |
CN114177278A (zh) * | 2021-10-18 | 2022-03-15 | 山东多美康生物医药有限公司 | 脂质体制备 |
CN114470057B (zh) * | 2021-10-26 | 2023-12-22 | 成都科建生物医药有限公司 | 一种脂质体皮肤修复制剂及其制备方法 |
CN114470171B (zh) * | 2021-12-31 | 2024-06-11 | 江苏聚源医疗技术有限公司 | 胶原蛋白脂质体冻干乳及其制备方法 |
CN115177535B (zh) * | 2022-05-27 | 2023-07-07 | 吉林省中鹿中医药产业(集团)有限公司 | 鹿皮胶原蛋白多肽脂质体水凝胶、制备方法及其应用 |
CN116270296B (zh) * | 2023-04-13 | 2024-10-22 | 时垠(上海)生物科技有限公司 | 胶原蛋白脂质包裹体及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102397168A (zh) * | 2011-11-23 | 2012-04-04 | 苏州瑞纳生化技术有限公司 | 用于化妆品的带电荷柔性纳米脂质体及其制备方法 |
CN102429913A (zh) * | 2011-12-13 | 2012-05-02 | 江苏圣宝罗药业有限公司 | 复方丙酸氯倍他索脂质体及其制剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004323401A (ja) * | 2003-04-23 | 2004-11-18 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
JP2005060234A (ja) * | 2003-08-08 | 2005-03-10 | Rohto Pharmaceut Co Ltd | 皮膚外用剤 |
-
2013
- 2013-01-25 CN CN201310030618.8A patent/CN103110935B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102397168A (zh) * | 2011-11-23 | 2012-04-04 | 苏州瑞纳生化技术有限公司 | 用于化妆品的带电荷柔性纳米脂质体及其制备方法 |
CN102429913A (zh) * | 2011-12-13 | 2012-05-02 | 江苏圣宝罗药业有限公司 | 复方丙酸氯倍他索脂质体及其制剂 |
Non-Patent Citations (2)
Title |
---|
JP特开2004-323401A 2004.11.18 |
JP特开2005-60234A 2005.03.10 |
Also Published As
Publication number | Publication date |
---|---|
CN103110935A (zh) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103110935B (zh) | 皮肤局部用水解胶原蛋白脂质体及其制备方法 | |
CN108882951B (zh) | 保湿组合物及其用途 | |
RU2637443C2 (ru) | Проникающие через кожу композиции на основе гликозаминогликана для местного применения в косметических и фармацевтических целях | |
WO2014044808A2 (en) | Fast-penetration cosmetic dermal filler for topical application | |
KR102452905B1 (ko) | 천연 스피큘과 폴리디옥사논을 함유한 피부개선 화장조성물 제조방법 및 그 화장조성물 | |
KR101895038B1 (ko) | 스피큘을 포함하는 용해성 필름 및 이의 용도 | |
CN108135972B (zh) | 贻贝粘蛋白产品治疗和预防黑色素相关疾病中的应用 | |
CN104780902A (zh) | 外用组合物 | |
CN112294666B (zh) | 一种具有促渗透功能的硅凝胶眼霜 | |
KR20180069487A (ko) | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 | |
EP2906193B1 (en) | Modified hyaluronic acid derivatives and use thereof | |
CN1864753A (zh) | 贴剂 | |
US20240100085A1 (en) | Methods and compositions for therapeutic skin treatments in dermatological procedures affecting skin's barrier | |
CN108785128A (zh) | 一种聚丙二醇修饰的水解胶原蛋白脂质体及其制备方法 | |
CN1285193A (zh) | 透明质酸口服美肤保健品的制备和应用 | |
RU2805144C1 (ru) | Рекомбинантный ангиогенин в косметических и фармацевтических композициях | |
KR20200062071A (ko) | 지방 생성을 자극하는 펩타이드, 조성 및 방법 | |
CN106333955A (zh) | 人参皂苷Rk3在制备防治毛细血管扩张症药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 214000, 35, Jing Xin Road, tin Beizhen Industrial Park, Xishan District, Jiangsu, Wuxi Patentee after: Jiangsu Sempoll Pharmaceutical Co., Ltd. Address before: 214111 Jiangsu Province, Wuxi City District Town Square Xinming Road No. 29 Patentee before: Jiangsu Sempoll Pharmaceutical Co., Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: JIANGSU ZHIYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: JIANGSU SHENGBAOLUO MEDICINE INDUSTRY CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 214000, 35, Jing Xin Road, tin Beizhen Industrial Park, Xishan District, Jiangsu, Wuxi Patentee after: JIANGSU ZEYUN PHARMACEUTICAL CO., LTD. Address before: 214000 Jiangsu Province, Wuxi City District Town Square Xinming Road No. 29 Patentee before: Jiangsu Sempoll Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 35, Jingxin Road, industrial park, Xibei Town, Xishan District, Wuxi City, Jiangsu Province, 214000 Patentee after: Jiangsu Zhiyuan Pharmaceutical Co.,Ltd. Address before: No. 35, Jingxin Road, industrial park, Xibei Town, Xishan District, Wuxi City, Jiangsu Province, 214000 Patentee before: JIANGSU ZHIYUAN PHARMACEUTICAL Co.,Ltd. |